DATATRAK Teams with Clinverse, Inc. to Drive Costs Out of Clinical Trials - ABC 33/40 - Birmingham News, Weather, Sports

DATATRAK Teams with Clinverse, Inc. to Drive Costs Out of Clinical Trials

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE DATATRAK International, Inc.

DATATRAK Connect™ Technology Partner Program Thriving

CLEVELAND, Jan. 21, 2014 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced its newest DATATRAK Connect™ Technology Partner, Clinverse, Inc. Clinverse architected the industry's first end-to-end technology solution that automates the financial lifecycle of global clinical trials.

By implementing ClinPay®, Clinverse's flagship product, sponsors and CROs reduce workload, time, and related costs. ClinPay provides complete real-time, role-based visibility into and control over the financial status of their clinical trials, including payments, invoicing, and cash management.

"Clinverse and DATATRAK share common goals, focused on reducing complexity and costs typically associated with clinical trials," said Tim Lyons, Senior Director, DATATRAK Clinical Consulting Services. "Working together, DATATRAK ONE® and ClinPay seamlessly integrate, automating payments based on real-time data. Streamlining the payment process delivers enhanced data quality, trial safety, and efficiency for our partners, leveraging the most efficient financial tool on the market."

"DATATRAK is an ideal partner for our solutions," said Jeff Rogers, Chief Commercial Officer of Clinverse. "The many benefits of ClinPay can be realized in a true real-time single database architecture, which DATATRAK delivers. Our expertise in global currencies and trials reduces complexity and enhances efficiencies for all trial phases."

To find out how DATATRAK can help reduce risk, improve data quality, and provide efficiency to your trial, visit us at www.datatrak.com

Join DATATRAK Thought Leaders:

Tweet: Thrilled to add @ClinverseInc to #DATATRAK Connect #Technology Partner program Driving cost out of #clinicaltrials http://bit.ly/1dOn9ge

About DATATRAK
DATATRAKInternational is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAKONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.com.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 14, 2013 announcing its results for the third quarter of 2013. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

About Clinverse, Inc.
Clinverse, Inc. architected the industry's first end-to-end financial lifecycle solution for automating clinical trial finance and payments on a global scale. Used by leading BioPharma companies, our clients benefit from reduced workload, time, and costs through total automation and unprecedented transparency and workflow. Powered by our highly secure technology platform, our solutions standardize clinical trial financial processes and manage millions of global financial transactions throughout the world. For more information, please visit www.clinverse.com.

©2012 PR Newswire. All Rights Reserved.